John Anto Pulikkan, PhD, a post-doctoral associate in the laboratory of Lucio H. Castilla, PhD, associate professor of molecular medicine and biochemistry & molecular pharmacology, received a 2012 Scholar Award from American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders. Dr. Pulikkan was one of seven basic research fellows from across the country to receive the award.
Ira Ockene, MD, the Barbara D. Milliken Professor of Preventive Cardiology and professor of medicine, was interviewed on 90.9 WBUR’s RadioBoston Tuesday, Dec. 20, on the recently published findings of UMass Medical School’s Lawrence Latino Diabetes Prevention Project. Ockene, principal investigator of the study, explained to host Meghna Chakrabarti how the modest weight loss by participants was enough to significantly lower their risk of diabetes.
Advantagene Inc. and UMass Medical School have announced the beginning of a Phase III clinical study to test the ability of a novel immunotherapy to kill tumor cells and stimulate a patient-specific anti-tumor immune response for patients newly diagnosed with localized prostate cancer.
A paper authored by researchers in the Department of Quantitative Health Sciences was nominated by the Robert Wood Johnson Foundation as being one of the 20 most influential research articles of 2011. Now the public will determine which of these top 20 papers will be in the “Final 5,” to be announced in January 2012.
The Worcester Telegram & Gazette’s editorial page today followed up on a recent profile piece of former Gov. Paul Cellucci and his work to raise money for amyotrophic lateral sclerosis (ALS) research at UMass Medical School. Cellucci was featured in Sunday’s Worcester Telegram & Gazette, talking about the status of his campaign to raise $10 million for ALS research.
An inexpensive, culturally sensitive diabetes prevention program created by researchers at UMass reduced pre-diabetes indicators in a Latino population at risk for developing diabetes. Results of this three-year study, which were published online yesterday in the American Journal of Public Health, are significantbecause they replicate results of similar studies that were carried out in more educated and higher-income populations, and much more expensive to conduct. The model for the Lawrence intervention could provide an affordable approach for similar low-income populations.
UMass Medical School diabetes and wound care specialists are assisting a Worcester Polytechnic Institute research team on a $1.2 million award from the National Science Foundation to develop a smart phone application for people with advanced diabetes and foot ulcers. The four-year project, organized through WPI's Healthcare Delivery Institute, is designed to help patients better manage their disease.
The United States Patent and Trademark Office has reaffirmed the validity of four important patents in the field of RNA therapeutics. The affirmation validates the inventions known as the Zamore Design Rules, compositions and methods of designing double stranded RNAi agents having decreased off-target silencing activity through certain structural modifications.